In a Truth Social post, Trump noted that the White House would place a 100% tariff on “any branded or patented” pharmaceutical product — unless a company was investing in manufacturing facilities in ...

After Emma Walmsley steps down as GSK CEO in January, Vertex Pharma’s Reshma Kewalramani will be the sole female CEO at a top ...

Royalty Pharma plc (Nasdaq: RPRX) today announced that the independent directors of the Board have unanimously appointed Dr. Ted W. Love, an independent director since 2020, as Lead Independent ...

International companies with heavy Massachusetts footprints are largely protected by that caveat. Drug makers from Moderna to ...

Global drugmakers are scrambling to shore up their U.S. manufacturing capacity and domestic inventory as the Trump ...

The FDA re-approved Wellcovorin, a drug from GSK, that the company stopped selling more than 25 years ago, as part of a push from the Trump administration to identify the causes of and potential ...

US President Donald Trump has dropped a bombshell on the pharmaceutical world, announcing a 100 per-cent tariff on all imported branded and patented drugs, effective 1 October. Generic medicines, the ...

The purchase gives Biogen full access to an implantable device that could help patients avoid the repeat lumbar punctures ...

Trump drug tariffs announced 100% duties on branded drugs by October 1st, impacting global pharmaceutical manufacturers, ...

Non-nephritis lupus and lupus nephritis may actually be part of a spectrum of diseases rather than different conditions, ...

Royalty Pharma plc (Nasdaq: RPRX) today announced that it will participate in a fireside chat at Bernstein’s 2nd Annual Healthcare Forum on Tuesday, September 23, 2025 at 2:50 p.m. ET. The webcast ...

Investing.com -- BioPharma Credit Plc (LON:BPCR) on Monday reported a return on ordinary activities after finance costs and ...